A brief review is given of data analysis methods for the identification and quantification of associations between environmental exposures and health events of interest. Data analysis methods are outlined for each of the study designs mentioned, with an emphasis on topics in need of further research. Particularly noted are the need for improved methods for accommodating exposure assessment measurement errors in analytic epidemiologic studies and for improved methods for the conduct and analysis of aggregate data (ecologic) studies. -Environ Health Perspect 101 (Suppl 4): 39-48 (1993).
Introduction
Nearly all study of the health consequences of environmental and lifestyle exposures in human populations is purely observational. This means that the validity of the comparison of disease rates between more exposed and less or nonexposed persons is dependent on the assumption that disease rates in the two groups are comparable in the absence of such exposure. This comparability assumption can be weakened somewhat by the measurement and accommodation of other factors that are associated with disease risk and that have a different distribution in the compared exposure groups. If such confounding factors are accurately measured and adequately acknowledged in the data analysis, it is then sufficient that in the absence of the exposure of interest, the groups being compared have common disease rates conditional on the values of the confounding factors. Lack *Author to whom correspondence should be addressed.
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or the health effects under study are not measured accurately. In practice these sources of bias can be reduced, but it is unliklly that they will be completely eliminated.
The sources of bias mentioned here are the principal reasons why epidemiologic cohort studies, among others, may yield inaccurate and conflicting results. Concern about residual, uncontrolled confounding can never be completely eliminated in any nonexperimental study. Hence, such studies are most reliable for the detection of moderate to large health effects (e.g., increase in disease incidence by a factor of two or more among highly exposed persons) that are unlikely to be qualitatively affected by modest confounding. There is also a strong role for the replication of results in diverse populations that are presumed to have different potentials for severe confounding. It Apparent disagreement between environmental epidemiologic studies can also arise, not from bias, but from lack of power combined with attention to point estimates rather than confidence limits. The ability to detect an association between the levels of an exposure variable or exposure history and the risk ofa disease depends primarily on the observed number ofdisease events in the study sample, on the range of exposures in the sample, and on the strength of association between exposure and disease. The distribution of exposures in the study cohort or in the cohort from which cases and controls are selected for a case-control study also has important influences on study power. While random measurement error in (univariate) exposure assessment will not invalidate, under weak conditions, a test for the hypothesis that no association between exposure and disease exists, test power may be reduced considerably by such measurement errors. Also, estimates of dose-response parameters may be substantially distorted (usually biased downward), induding the possibility of a loss of monotonicity of dose-response trends (1) . Thus, the proper analysis and interpretation of environmental epidemiologic studies rely heavily on the investigator's assessment of the magnitude of both potential biases and study power in the absence of such biases. For practical reasons, the power of specific studies will often be rather low, and knowledge of disease mechanisms and measurement properties will be too limited to place usefid bounds on potential biases. Hence, there are important uses for formal tests of the equality of exposure-disease associations from two or more studies in differing populations and for techniques used in combining the results of several studies. This topic will be discussed in the section tided "Comparing and Combining the Results of Several Studies."
The following section describes statisticaland biological-based models that can serve as the basis for exposure-disease analyses.
Models for Disease Occurrence
The simplest cohort studies occur The result is a simple proportional hazards (or Cox) model X(tIZ) + ko(t)exp(Xi) [1] which is used widely in the analysis of failure time data (2) . In order to deal with complications inherent in most environmental epidemiologic studies, one must generalize this discussion and complicate the appearance of some formulae, but be careful not to change the essentials of the approach. Such generalization follows in the next subsection.
Descriptive Relative-Risk Models As above, let k0 (t) denote the instantaneous rate of a study disease (or other health-related problem) at age t in the absence of the exposure of interest. A person of age t may have received exposures z(u) at certain ages u < t. One can refer to Z(t) = {z(u), u < t} as the person's exposure history up to age t. Furthermore, one can allow the vector z(u) to indude the values of confounding factors at age u, so that Z(t) indudes both exposure and confounding factor histories up to age t. The disease rate at age tis X{tIZ(t)}, a function of this exposure and confounder history. The relative risk associated with history Z(t) is then the ratio X{tIZ(t)}/ ko(t). Because this ratio is nonnegative, it can be, and often is, modeled using an exponential function exp{X(t)P}, where X(t) = {X1(t),...,X(t)}. This function consists of data-analyst-defined functions of Z(t) and t, with X(t) (0...0) again corresponding to no exposure and standard confounder histories, while pT= (Pi'. . is a corresponding vector of relative-risk parameters to be estimated.
This relative risk (RR) regression model X{tIZ(t)} = X0(t)exp{X(t)P} [2] also called the Cox-regression model or (inaccurately called) the proportional hazards model (2) (3) (4) or an approximation to these models, forms the basis for most descriptive analyses of environmental epidemiologic studies. As a simple example to illustrate the notation, consider the relationship between exposure to ionizing radiation and the rate of a certain cancer in the atomic bomb-exposed populations in Hiroshima and Nagasaki. One could define z(u0)T = {Z1(U0),Z2(U0)}, [3] as the gamma and neutron exposures for a person at age u0 in 1945 when the exposure occurred and as z(u) _ 0 otherwise. A specification X(t) _ z(u0) then assumes a log-relative risk function that is linear in gamma and neutron exposure levels. The regression model can be relaxed to allow, for example, the relative risk to depend on age at exposure and time since exposure and to allow for nonlinear dependencies of the log-relative risk on gamma and neutron exposure. As noted above, the histories of potential confounding factors can also be induded in Z(t), in which case X(t) will indude functions of both the exposures of interest and other factors, while product terms between the two will allow the relative risk associated with a given exposure history to depend on the value of other variables. This allowance is termed effect modification in epidemiologic parlance. Confounding factors may also be controlled by means of stratification rather than, or in addition to, regression modeling using the descriptive model X{ttZ(t)} = Xo,(t)exp{X(t)P} [4] where the baseline rate X4(o) is allowed to vary across a number of strata defined as functions ofage (4 and confounding factor values.
Relative-risk forms other than exponential also may be considered in the above models.
In particular, the linear form 1 + X(t)p often is felt to be theoretically and empiricaly more appropriate for certain carcinogenic exposures and has been used widely in radiation literature, sometimes with the addition of quadratic terms. Absolute rather than relative-risk models, such as {,tIZ(t)} = X?"(t) + X(t)P, [5] also have been used in modeling radiation effects, although there is a consensus that it generally does not fit well without the addition of terms for the modifying effect of age at exposure and latency. It may also be useful for modeling certain rare diseases such as mesothelioma, for which the baseline rate in the absence of asbestos exposure is virtually zero. In all of these alternatives to the standard exponential relative-risk model, estimates of the relative-risk parameters and baseline rates are often found to have poor statistical properties. However, quite general programs that use likelihood-based methods to obtain appropriate confidence limits (5) are now available to fit a broad class ofrelativeand absolute-risk models with combinations of linear and exponential terms.
Suppose that the regression vector X(t) in the above unstratified model consists only of functions of the exposure variable under study, and let pr{X(t)} denote the probability density for value X(t) in the source population of the modeled regression vector. In addition to estimating the relative-risk function, one may be interested in the fraction of the disease incidence at age t that may be attributed to exposure. If the disease rate for all study subjects was reduced to the baseline rate 4(t), then the overall incidence at age t would be reduced by the attributable proportion
pr{X(t) }d%(t)/JXo(t) exp{X(t) }pr{X(t)}d%(t). [6] A similar expression can be written for the attributable proportion under the stratified relative-risk model. In some applications of these relative-risk models, it is convenient to define the basic time variable t to be chronological time or time from entry into a certain cohort rather than age, which is accommodated through stratification or regression modeling. For example, in a cohort study with covariate information collected at specified points in chronological time, such a definition can help ensure comparability of the covariate (i.e., exposure and confounding) information on all study subjects at a given value of t.
There are distinct advantages in using hazard rates or instantaneous disease rates, X{tIZ(t)}, in our formulae rather thanddisease rates over some specified age or time period, in part because the interpretation of these latter rates will depend on the duration of the age period or time period in question, which will vary inevitably from study to study. Nevertheless, in some studies one observes only whether disease occurs in a certain time period rather than the actual times or ages of disease occurrence. Let D = 1 denote disease occurrence during a prescribed disease ascertainment period for a study and D = 0 denote lack of occurrence. Ignoring issues such as competing risks and losses to follow-up, one may choose to model the disease probabilities pr{D = I I Z(tO)} by an exponential-form odds-ratio model in which pr{D = 1 I Z(to)1 / prD= 1 I Z(to) = Zo pr{D =°Z(to)1 / pr{D= O Z(to) = Zo} = exp{X(to)|}, [7] where Z(to) denotes a subject 
Mecanistic and Biologicliy

Based Moddls
Efforts to describe a disease process in terms of deterministic or stochastic models have focused mostly on models for the spread of infectious diseases in a population and models for carcinogenesis. Some of the work on carcinogenesis models, as outlined below, may be pertinent to other diseases.
Much of the early work on mathematical models for cancer was reviewed in a classic paper byArmitage and Doll (6) . Whittemore and Keller (7) Until recently, most of the empirical tests of these predictions have been done by fitting the model to aggregate data on population age-specific rates, or to broadlygrouped data on cohorts, stratified by dose, age at exposure, or time since exposure. A problem with this approach is the difficulty of separating the effects of dose rate, age at first exposure, duration of exposure, time since last exposure, and attained age, all of which influence the predictions of the model. Simple comparisons of one factor without controlling the other factors can be misleading. This is less of a problem when animal bioassay data are used, as these are usually limited to constant, lifetime, dose regimens. However, such data are not informative about whether the carcinogen acts at an early or late stage. Nevertheless, the approach has been used for risk-assessment purposes by many regulatory agencies. The default approach advocated by the U.S. Environmental Protection Agency (EPA) and others involves fitting the multistage model to available epidemiologic or toxicologic data and using an upper confidence limit on the estimated slope coefficient (scaled for species differences in weight and life span) to compute the lifetime excess risk in humans. The scientific and statistical validity of this approach is controversial (8, 9) .
With the development of general relative-risk models ("Descriptive Relative-Risk Models" above), it has become possible to test the multistage and other models by fitting them directly to data on individuals. This offers great advantages for dealing with time-dependent exposures, which are the most informative about the stage at which a carcinogen acts. This approach has been applied to data on occupational exposures to asbestos (10) , arsenic (11) , and benzene (12) ; on the atomic bomb survivors (13) ; and on smoking (14) (15, 16) , breast cancer (17) , and radon (18) . In the latter example, data from an experimental study of rats expsed to radon were fitted to the model and radon was found to have an effect on both the mutation and proliferation rates. However, the interpretation of this result is complicated by the authors' use, for both of these dependencies, of a power function dose-response relationship with a very low exponent rather than a simple linear dose-response. Thomas (19) (5) that is a product over all disease occurrence times (ages) that appear in the sample of the ratio of the relative risk for the subject developing disease to the sum of the relative risks for all subjects at risk at that time (20) . The corresponding likelihood function under the above stratified relative-risk model is simply the product over strata of the stratum-specific likelihood functions. Note that this estimation procedure is quite general in that exposure variables, confounding variables, and stratum assignments each can vary with follow-up time. The principal assumption underlying this estimation procedure requires the set of subjects at risk for disease at any follow-up time to be representative of the base population, conditional on the covariate history and stratum assignment. This assumption will be satisfied, for example, if study subjects are sampled randomly and independently from the study population, and if rates of censoring (e.g., losses to follow-up) at a given follow-up time depend most on the covariate histories and stratum assignments at that time. Also, under weak conditions, L(O) can be manipulated as if it were an ordinary likelihood function for asymptotic inference on , (21, 22 Consider the unstratified relative-risk regression model of "Relative-Risk Models" and suppose that rather than the covariate history Z(t) one observes an estimate W(t). The disease rate function at age (or chronological time) t, given the observed covariate history W(t) can then be written (26) X{t;W(t)} =k(t)E[exp{X } W [11] where the expectation also is conditional on lack of disease occurrence or censorship prior to t. In fact, this induced relative-risk model also requires X{t; Z(t), W(t)} = {t; Z(t) } [ 1 2] so that the W(t) is unrelated to disease risk, given the true covariate history Z(t). Unfortunately, the expectation in X{t; W(t)} generally depends on the baseline rates 0(u), u . t, which complicates the estimation. However, in cohort studies in which the cumulative probability of disease occurrence is small, this dependence usually can be ignored and estimation of ,B can be based on a likelihood function in the form described above upon specifying a measurement error distribution for X(t) given W(t), from which X{t;W(t)} can be calculated.
Specification of the distribution of X(t) (36) and Thomas et al. (37) . Another recent development involves combining nonparametric density estimation techniques with a computational device known as Gibbs sampling to overcome the tractability problems in the Clayton approach and avoid the need for parametric assumptions about the distribution of true doses. This method has been applied to data on studies of leukemia and thyroid disease in Utah residents downwind of the Nevada Test Site (38, 39) . These approaches are in an early stage of development, but they offer the prospect of removing the bias due to misclassification, correcting the shapes of dose-response curves, adjusting for covariates, and examining interaction effects, all while allowing for the additional uncertainties due to uncertainties in exposure estimates. Further developments along these lines are highly desirable.
Most of the literature on correcting for measurement errors has assumed that the misdassification rates were known and were constant across subjects. In practice, only estimates of these error distributions are available, either from earlier validation studies, from replicate measurements, from gold standard measurements on a subset of the subjects, or from theoretical uncertainty analysis. Methods need to be developed to account for uncertainties in the estimates of these misclassification rates (40) . As a design issue, the optimal allocation of resources between highquality measurements on a subset and larger numbers of approximate measurements should be considered (41, 42 Consider the stratified relative-risk model of "Relative-Risk Models" and suppose that each case has one or more randomly selected controls that are matched on age at ascertainment (t) and stratum (s). Given the covariate histories {Z1(t),..., Zm(t)} for a case and its (rn1) age-and stratum-matched controls, the probability that exposure history Z1 (t) corresponds to the case is simply the relative risk at t for the case divided by the sum of such relative risks for the n-matched subjects (including the case). Hence, the relative-risk parameter , can be estimated by maximizing the likelihood function L(f3), which is formed by multiplying these ratios for all matched case-control sets (43) . To avoid strict matching on (t,s), relaxations of this sampling scheme are possible.
Similarly, the odds-ratio parameter P in the logistic regression model of "RelativeRisk Models" can be estimated under case-control sampling by maximizing the resulting logistic regression likelihood function by acting as though a prospective study had been conducted, though the estimates of as no longer reflect disease incidence probabilities (23) . In fact, the baseline rates XOs(@) and axs in the relativerisk and odds-ratio regression models of "Relative-Risk Models" cannot be identified from case-control data in the absence of additional information on case and control sampling fractions.
In general, relative-risk and odds-ratio parameter estimates from case-control studies will be subject to the same biases as cohort studies. They also may be subject to recall bias if exposures or other covariate histories are differentially recalled by cases and controls or if they involve measurements that are affected by disease occurrence or its sequelae. There are often various practical steps that can be taken to minimize bias in ascertaining the covariate histories Z(t) (e.g., interviewers blinded to case or control status), but usually it is not possible to identify residual recall bias because the requirement to obtain prediagnosis and postdiagnosis covariate histories on a sufficient sample of cases would often eliminate much of the efficiency of the case-control design.
As with the cohort study design, nondifferential measurement errors lead to the expectation E [exp{X(t) } I W(t)]' [13] where X(t) is the true and W(t) is the measured regression vector at age t, as the identifiable relative-risk function under age-and stratum-matched case-control sampling. To the extent that a representative validation sample can be ascertained retrospectively, there will be a potential to conduct valid relative-risk estimation from this type of study without making further assumptions.
A case-cohort (case-base) sampling procedure can also be considered as a means of reducing the cost or simplifying the logistics of a cohort study. With this design, covariate histories Z(t) are assembled only for cases and a (stratified) random sample of the study cohort. This sampling procedure has advantages if several end points (diseases) are to be studied in relation to an exposure. Also, the subcohort may be used to monitor exposures and other variables during the study's follow-up. However, estimation may be less efficient than estimation based on a case-control study with a comparable number of study subjects if cases and subcohort members are not well matched (44, 45) , and recall bias typically will be an issue. Prentice (46) has developed a procedure for estimating the relative-risk and odds-ratio parameters from case-cohort samples, and, in contrast to case-control sampling, baseline rates also can be estimated without external information. Comparisons and refinements of these sampling procedures are worthwhile research activities. Note also that the use ofso-called two-stage designs (47, 48) can lead to further valuable efficiency gains in some case-control study applications.
Exposure-esponse Estimation in Aggregate Data (Ecologic) Studies
As discussed previously, sometimes it will be economical and convenient to examine an exposure-disease association by relating the disease rates among several groups of individuals to aspects of the exposure experience of each group. Such studies can be referred to as aggregate data studies since they involve the disease rates and exposures for the aggregate, rather than for individuals. These studies also are commonly referred to as ecological studies since groups having differing exposure histories are sometimes defined on an ecologic or geographic basis.
Denote by Xki(t) the age-and sex-specific disease rate in the kh group during (chronological) time period t. A multiple group study involves the analysis of estimates of Xki(t), k = 1,...,Kduring a fixed time period; a time trend study involves estimates of Xki(t), t = 1,..., Tin a single population, while a mixed study involves estimates of Xki(t) at several values of both k and t. An exponential-form relative-risk model for Xki(t) can be written, in the notation of "Relative-Risk Models," as Xki(t) = Xko(t)exp{Xki (t)13}, [14] from which the average disease rate Xk(t) for the nk(t) individuals in group k during time period t is nk(t)
where Xk(t) = nk (t)Xki (t) and dki (t) = Xki (t) -Xk (t) [17] Letyk(4 denote the observed age-and sex-specific dise incidence rate in group k during time period t as may be available from a disease register or other admininstrative source. From the above expression for Xk(t), one expects a regression of log Yk(t) on Xk(t) for various values of kor t(or both) to yield biased extimates of the relative-risk parameter P, because of the influences of the residuals dki(t), even if the logarithms of the baseline rates Xko(t) can be regarded as independent random variables with a common mean. This specification bias will be small if the dki(t) values are small, that is, if the exposure and other regression variables have little variation within groups. Such bias presumably can be reduced by extending the regression equation to indude averages ofsquares and ofhigher powers of the dki(t) terms, though there does not appear to have been specific study of this approach. A dosely related approach would replace the exponential-form relative-risk model by a linear-form model, so that and Xki(t) = XkO(t){ 1 + Xki (t)13} [18] Ak(t) = XkO(t){ 1 + %*(t)*} [19] from which the regression of yk(t) on Xk(t), under certain random-effects assumptions on the baseline rates {kko(t)}, will yield valid estimates of the linear relative-risk parameters (49) . Note, however, that an exponentialform relative-risk model often might be more parsimonious than a linear-form model in environmental epidemiologic applications so that the regression vector in a linear relativerisk model may need to be quite lengthy and involve, for example, the average of product terms between exposure and potential confounding factors in order to adequately describe the data. In a multigroup study, it may be sensible to assume the ko(t) terms are independent random variables with a common mean for k = 1,...,K thought it often may be useful to allow for the possibility of correlation among groups in a similar geographic area. In time-trend and mixed studies, however, it will typically be essential to model, or otherwise accommodate, the correlation structure among Xko(t), t= 1,...,Tat any fixed k. Inadequate modeling of the {Xko(t)} may lead to aggregation bias. Morgenstern and Thomas, in this volume, mention certain designs other than those discussed thus far in this artide, as well as the use of biomarker endpoints. Corresponding data analysis issues and methods will be mentioned only briefly here.
It was noted that experimental designs are practical occasionally in environmental epidemiologic research. The relative-risk and odds-ratio regression methods described above apply equally well for the comparison of disease incidence (or mortality) rates between randomization groups in individually randomized designs. However, a group-randomized design (e.g., with community as the unit of randomization) is more likely to be feasible, in which case it is essential to acknowledge the possibility of correlation among the responses (e.g., disease incidence times) of subjects in the same randomization group, which require the use of the type of correlated failure-time methods mentioned above.
In the discussion of ecologic designs it was noted that descriptive studies of the cluster- (61) and other papers in this volume for discussions of disease-clustering methods.
The design chapter (in this issue) also emphasizes cross-sectional studies for the estimation of prevalence rates. The logistic regression methods outlined in "RelativeRisk and Odds-Ratio Estimation" may be used to relate prevalence probabilities to retrospectively obtained exposure and confounding factor histories. Of course, such prevalence probabilities reflect aspects of both disease incidence and disease duration, and therefore, may be difficult to interpret. Keiding (62) provides a comprehensive discussion of the relationships between prevalence probabilities, incidence rates, and disease durations and of the possibility of deriving estimates of age-specific incidence from cross-sectional studies.
As discussed previously, biomarkers may serve usefully as exposure indicators or as early indicators of disease (see Hatch and Thomas, this volume). An example of a biomarker as an intermediate endpoint is seen in chromosomal abnormalities in the radiation-exposed cohorts of Hiroshima and Nagasaki. The rates of such abnormalities among long-lived lymphocytes (usually 100 cells examined for each subject) have played a useful role in assessing the health effects of radiation exposure in these populations.
The correlation among the chromosomal events in cells from the same study subject has a strong influence on dose-response analyses in this application (35, 63 
Summary Recommendations
Perhaps the single most important data analysis research need in environmental epidemiology concerns the development of improved methods to accommodate measurement errors in exposure assessment. Efforts aimed at the design and use of validation studies would be particularly useful, as would studies to document the scope and magnitude of measurement error influences.
A second important need concerns improved methods for the conduct and analysis of aggregate data (ecologic) studies. The development of strategies for controlling potential confounding, particularly by using individual surveys in multigroup studies, along with corresponding innovative data analysis methods, will be important. Empirical studies that illustrate various analytic and aggregate data analyses of real data sets also would be valuable.
Other pertinent topics for data analysis reech indude the development ofimproved methods for meta-analyses when studies of different types with differing potential for measurement error biases are available, the development of flexible data analysis methods, and the study of properties of analyses based on biomarker indicators of exposure or biomarker end points. Studies that evaluate and compare strategies for the control of confounding also merit continuing attention in environmental epidemiology as in other observational research areas. Further work on biologically based mathematical models for cancer and for other disease also would be well motivated. en
